Sapna Srivastava - Net Worth and Insider Trading

Sapna Srivastava Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sapna Srivastava owns 9 companies in total, including Intellia Therapeutics Inc (NTLA) , Myos Rens Technology Inc (MYOS) , and MedAvail Holdings Inc (MDVLQ) among others .

Click here to see the complete history of Sapna Srivastava’s form 4 insider trades.

Insider Ownership Summary of Sapna Srivastava

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2016-05-05 Chief Financial & Stategy Offr
MYOS Myos Rens Technology Inc 2015-01-12 director
MDVLQ MedAvail Holdings Inc 2013-02-08 director
LIMIT LIMIT 2021-10-28 director
LIMIT LIMIT 2020-10-29 director
LIMIT LIMIT 2021-05-06 director
LIMIT LIMIT 2021-06-29 director
LIMIT LIMIT 2021-07-28 director
LIMIT LIMIT 2023-01-01 director

Sapna Srivastava Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sapna Srivastava Ownership Network

Ownership Network List of Sapna Srivastava

No Data

Ownership Network Relation of Sapna Srivastava

Insider Network Chart

Sapna Srivastava Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Sapna Srivastava is the Chief Financial & Stategy Offr of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Sapna Srivastava made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Sapna Srivastava Mailing Address

Above is the net worth, insider trading, and ownership report for Sapna Srivastava. You might contact Sapna Srivastava via mailing address: C/o Myos Corporation, 45 Horsehill Road, Suite 106, Cedar Knolls Nj 07927.